E-Therapeutics Plc (ETXP)

London
17.36
+0.39(+2.28%)
  • Volume:
    13
  • Bid/Ask:
    16.50/17.75
  • Day's Range:
    17.36 - 17.36

ETXP Overview

Prev. Close
16.98
Day's Range
17.36-17.36
Revenue
296K
Open
17.36
52 wk Range
14.5-34.8
EPS
-0.019
Volume
13
Market Cap
101.06M
Dividend (Yield)
N/A
(N/A)
Average Volume (3m)
78,040
P/E Ratio
-9.14
Beta
0.6
1-Year Change
-47.27%
Shares Outstanding
582,159,332
Next Earnings Date
01 May 2023
What is your sentiment on E-Therapeutics?
or
Vote to see community's results!

E-Therapeutics Plc Company Profile

E-Therapeutics Plc Company Profile

e-Therapeutics Plc provides computer-based drug discovery platform. The Company's platform is a combination of databases and a suite of computational tools that employ network analysis, data mining, machine learning, artificial intelligence (Al) and optimization. Its in silico platform serves as a laboratory, which enables it to computationally test potential therapeutic interventions. Its network-driven drug discovery (NDD) technology performs computational phenotypic screens to identify efficacious drugs. Its genome-associated interactions networks (GAINs) technology interprets genomic data in the context of the biological networks, in which the genes function. Its ribonucleic acid (RNA) Interference, (RNAi) platform is in development to complement its computational toolset. The Company identifies new therapeutic approaches to modulate a specific mechanism involved in Idiopathic Pulmonary Fibrosis (IPF) and other fibrotic indications through Galapagos NV (Galapagos).

Read More

Technical Summary

Type
5 Min
15 Min
Hourly
Daily
Monthly
Moving AveragesStrong BuyStrong BuyStrong BuyNeutralStrong Sell
Technical IndicatorsStrong BuyStrong BuyStrong BuyBuyStrong Sell
SummaryStrong BuyStrong BuyStrong BuyNeutralStrong Sell
  • I guess people will reflect on the panic over the weekend and buy back on Monday.
    0
    • impressive 👍
      0
  • 35p
    0